The very first RECOMB webinar takes place on January 29, 15 CET and will introduce gene therapy for recombination-deficient severe combined immunodeficiency (RAG-SCID) and discuss how it will work for RAG1-SCID. It will also provide the latest status report and prospects of the project. RECOMB is a European multi-stakeholder research consortium aiming to create a novel treatment for SCID by conducting clinical trials using gene therapy for RAG-SCID. Ready to discuss these interesting topics are Prof Arjan Lankester, Prof Karin Pike-Overzet and Prof Frank Staal from Leiden University Medical Center, Netherlands. The webinar will be moderated by Mr Johan Prevot from the International Patient Organisation for Primary Immunodeficiency (IPOPI). REGISTER HERE The webinar will be held through the Livestorm platform and can be accessed both through your computer and your mobile device. It will also be recorded and published on the RECOMB website.
Not to be missed by all with an interest in in gene therapy for recombination-deficient severe combined immunodeficiency!